Vor Biopharma Soars 9.04% on Bullish Analyst Forecast

On August 13, 2025, Vor Biopharma's stock surged by 9.04% in pre-market trading, indicating a strong bullish sentiment among investors.

Vor Biopharma Inc. has recently received a new analyst forecast with a price target of $3.0, which could be a significant factor driving the stock's recent performance. This forecast suggests that analysts are optimistic about the company's future prospects, which may have contributed to the pre-market rally.

Additionally, Vor Biopharma has a consensus price target of $5.63, indicating a potential upside of 239.07%. This high price target reflects the market's confidence in the company's growth potential and could be another reason behind the stock's recent surge.